The price of IRD is predicted to go up 0%, based on the high correlation periods with LPTH. The similarity of these two price pattern on the periods is 95.47%.

IRD

LPTH

Up: 0%Similarity: 95.47%

IRD Revenue Forecast

IRD EPS Forecast

IRD FAQs

What is bull’s view on IRD?

The bull’s view on IRD stock is optimistic due to strong insider buying activity, including the CEO's recent purchase of 100,000 shares at $0.98, now trading at $1.23, reflecting a 26% gain. Analysts maintain a "Strong Buy" rating with a price target of $8.00, citing significant upside potential of over 600%. The stock's low valuation and insider confidence suggest a favorable growth trajectory.

What is bear's view on IRD?

The bear's view on IRD stock is cautious due to its current low trading price of $1.23, which is significantly below its analyst target of $8, indicating limited confidence in near-term growth. Despite insider buying, the stock's proximity to its 52-week low and lack of substantial positive catalysts suggest potential downside risk. Additionally, the healthcare sector's volatility and the company's speculative nature amplify concerns.